PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis
- 10 March 2017
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 33 (4) , 609-615
Abstract
Purpose Medulloblastoma (MB) is the most common malignant tumor of the central nervous system (CNS) in children. Despite its relative good survival rates, treatment can cause long time sequels and may impair patients’ lifespan and quality, making the search for new treatment options still necessary. Polo like kinases (PLKs) constitute a five-member serine/threonine kinases family (PLK 1–5) that regulates different stages during cell cycle. Abnormal PLKs expression has been observed in several cancer types, including MB. As gene regulators, miRNAs have also been described with variable expression in cancer. Methods We evaluated gene expression profiles of all PLK family members and related miRNAs (miR-100, miR-126, miR-219, and miR-593*) in MB cell lines and tumor samples. Results RT-qPCR analysis revealed increased levels of PLK1–4 in all cell lines and in most MB samples, while PLK5 was found underexpressed. In parallel, miR-100 was also found upregulated while miR-129, miR-216, and miR-593* were decreased in MB cell lines. Variable miRNAs expression patterns were observed in MB samples. However, a correlation between miR-100 and PLK4 expression was observed, and associations between miR-100, miR-126, and miR-219 expression and overall and event free survival were also evinced in our cohort. Moreover, despite the lack of association with clinico-pathological features, when comparing primary tumors to those relapsed, we found a consistent decrease on PLK2, miR-219, and miR-598* and an increase on miR-100 and miR-126. Conclusion Specific dysregulation on PLKs and associated miRNAs may be important in MB and can be used to predict prognosis. Although miRNAs sequences are fundamental to predict its target, the cell type may also be consider once that mRNA repertoire can define different roles for specific miRNA in a given cell.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/01026-8)
- Fundação de Apoio ao Ensino, Pesquisa e Assistência (2011/11287-3)
This publication has 42 references indexed in Scilit:
- Molecular Classification of MedulloblastomaNeurologia medico-chirurgica, 2016
- Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk ChildrenCancer Research, 2013
- From Plk1 to Plk5Cell Cycle, 2011
- Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell linesGenome Medicine, 2010
- Polo-like kinases: conservation and divergence in their functions and regulationNature Reviews Molecular Cell Biology, 2009
- MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell linesBiochemical and Biophysical Research Communications, 2008
- Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1α under Hypoxic ConditionsCancer Research, 2008
- Pharmacological and Functional Comparison of the Polo-like Kinase Family: Insight into Inhibitor and Substrate SpecificityBiochemistry, 2007
- Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissuesOncogene, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001